Synthesis, structural characterization and in vitro antitumor activity of 4-dimethylaminopyridinium (6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)methanides

被引:28
作者
Brzozowski, Z
Saczewski, F [1 ]
Gdaniec, M
机构
[1] Med Univ Gdansk, Dept Chem Technol Drugs, PL-80416 Gdansk, Poland
[2] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland
关键词
cancer-specific antitumor agents; structural characterization; aminium salts;
D O I
10.1016/j.ejmech.2003.09.007
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Previously, We have described a novel series of low molecular weight cancer-specific antitumor agents with aminium N-(1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamidate structure. In an attempt to determine some of the structural features that account for the cytotoxic activity of such aminium salts, a novel series of 4-dimethylaminopyridinium (1,1-dioxo-1,4,2-benzodithiazin-3-yl)methanides (6-19) has been synthesized by the reactions of 3-methylthio-1,4,2-benzodithiazine1,1-dioxides with 4-DMAP and some active methylene compounds. The in vitro antitumor activity of these compounds has been tested in the National Cancer Institute (NCI), and relationships between structure and antitumor activity are discussed. Among the aminium salts 4-dimethylamino-pyridinium 4-chlorobenzoyl cyano (6-chloro-7-methyl-1,1-dioxo-1,4,2-benzodithiazin-3-yl)methanide (9) was superior to other pyridinium salts in terms of both remarkable activity (log GI(50) and log TGI < -8.00) and high selectivity for the lung HOP-92 and melanoma UACC-257 cell lines. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:991 / 999
页数:9
相关论文
共 15 条
[1]  
BOYD M R, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P652
[2]   Synthesis, molecular structure and anticancer activity of 1-allyl-3-amino-2-(4-chloro-2-mercaptobenzenesulphonyl)guanidine derivatives [J].
Brzozowski, Z ;
Saczewski, F ;
Gdaniec, M .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (04) :285-293
[3]   Synthesis, structural characterization and in vitro antitumor activity of novel 6-chloro-1,1-dioxo-1,4,2-benzodithiazie derivatives [J].
Brzozowski, Z ;
Saczewski, F ;
Gdaniec, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (17) :3673-3681
[4]   A new type of mixed anhydride and its applications to the synthesis of 7-substituted 8-chloro-5,5-dioxoimidazo[1,2-b][1,4,2]benzodithiazines with in vitro antitumor activity [J].
Brzozowski, Z ;
Saczewski, F .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :430-437
[5]  
BRZOZOWSKI Z, 1984, ACTA POL PHARM, V41, P5
[6]  
BRZOZOWSKI Z, 1984, ACTA POL PHARM, V41, P133
[7]  
BRZOZOWSKI Z, 1993, ACTA POLON PHARM DRU, V50, P199
[8]   Sulfonamides and Sulfonylated Derivatives as Anticancer Agents [J].
Casini, Angela ;
Scozzafava, Andrea ;
Mastrolorenzo, Antonio ;
Supuran, Claudiu T. .
CURRENT CANCER DRUG TARGETS, 2002, 2 (01) :55-75
[9]   A novel kind of antitumour drugs using sulfonamide as parent compound [J].
Huang, ZH ;
Lin, ZL ;
Huang, JL .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (11-12) :863-872
[10]   FEASIBILITY OF A HIGH-FLUX ANTICANCER DRUG SCREEN USING A DIVERSE PANEL OF CULTURED HUMAN TUMOR-CELL LINES [J].
MONKS, A ;
SCUDIERO, D ;
SKEHAN, P ;
SHOEMAKER, R ;
PAULL, K ;
VISTICA, D ;
HOSE, C ;
LANGLEY, J ;
CRONISE, P ;
VAIGROWOLFF, A ;
GRAYGOODRICH, M ;
CAMPBELL, H ;
MAYO, J ;
BOYD, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) :757-766